North America Non-Invasive Fat Reduction Market

North America Non-Invasive Fat Reduction Market Size & Growth (2023 to 2028):

The size of the North America Non-Invasive Fat Reduction Market was valued at USD 0.50 billion in 2023 and is poised to reach USD 0.95 billion by 2028, predicted to be growing at a healthy CAGR of 13.87% between 2023 to 2028.

Due to increased demand for body sculpting and year-over-year increases in the number of obese and overweight people worldwide, the non-invasive fat reduction market in North America is predicted to grow quicker.

According to the Global Aesthetic Survey, the United States has the most cosmetic treatments, followed by Brazil.

Body contouring is a word that refers to a set of operations that can use to change the shape or look of the body, usually after a time of significant weight loss.

As body contouring grows more popular worldwide, the non-invasive fat removal market in North America will develop faster.

More than 75,000 people in the United States have body contouring procedures performed each year, although identical procedures are performed in some form worldwide. 

Furthermore, rising healthcare spending and investments are expected to propel the non-invasive fat reduction market in North America forward. In addition, in the coming years, the increased focus on body aesthetics in developed countries will benefit from increased body fat reduction activities. These reasons will substantially impact the market share of non-invasive fat reduction. 

Fat reduction surgery complications like seroma, infections, necrosis, and bruising might delay adoption for years.

Fat loss might take weeks or months to achieve and require multiple treatments. In addition, because nonsurgical liposuction is an external procedure, targeting the fat in question can be more difficult.

The high costs associated with non-invasive fat reduction treatment limit the market's growth. A lack of skilled and experienced physicians and a lack of knowledge in growing countries has hampered the non-invasive fat removal industry in North America. These factors are restraining the North America Non-Invasive Fat Reduction market during the forecasted period.

This research report on the North America Non-Invasive Fat Reduction Market has been segmented and sub-segmented into the following categories:

By Technology:

• Cryolipolysis

• Low-Level Lasers

• Ultrasound

By End User:

• Cosmetic Centers

• Dermatology Clinics

• Hospitals

By Country:

• The United States

• Canada

• Rest of North America

Geographically, North America presently dominates the market with 49.4 percent of revenue in 2022, which is expected to continue throughout the forecast period. 

The U.S Non-Invasive Fat Reduction Market is fuelled by more significant regional R&D, higher disposable income per capita, increased use of new technology, and ongoing public awareness campaigns. According to the International Society for Aesthetic Plastic Surgery, this region had the most nonsurgical treatments conducted in 2019, with 2,934,512 operations. In addition, men are becoming more accepting of these operations, as the number of men who have minimally invasive procedures rises year after year.

People's acceptance grows due to the rapid outcomes and spectacular benefits. The ease with which they may perform such operations and their price motivate millennials to choose non-invasive fat reduction therapies. Obesity affects 39.4% of the US population, according to a 2019 OECD report. This rate is more significant than in other OECD countries, with Mexico having the highest obesity rate at 34.3 percent of the population, making it the second most obese country globally. However, it is not as common in Canada's Non-Invasive Fat Reduction Market as in the United States and Mexico. Obesity affects 26.2 percent of the Canadian population, higher than the OECD average of 26.2 percent.

KEY MARKET PLAYERS

Prominent Companies dominating the North America Non-Invasive Fat Reduction Market Profiled in the Report are Fosun Pharmaceutical Co., Ltd., Cutera, Inc., BTL Industries, Invasix Aesthetic Solutions, Cynosure, Inc., ZELTIQ Aesthetics, Inc., Solta Medical, Syneron Medical Ltd. and Venus Concept.,